InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: Doc328 post# 165302

Friday, 09/14/2018 11:28:56 AM

Friday, September 14, 2018 11:28:56 AM

Post# of 462108
Doc328:

This seems to be good news.


I think many would agree with the Doc here. This SHOULD BE GOOD NEWS.

My question is, who is in charge? If other than FDA regulatory bodies are in use for trials does this give AVXL benefit, aside from the obvious cost? If this info suggests the PDD trials are underway why no sp reaction? Is sp the universal acceptance standard-news indicator? Before this gets too complicated w/multiple bodies involved, who will push the …"It's safe and effective" button when ready? Does it matter?

I trust this MB to find any defect before the ink is dry. Just when I think "I got it" something new comes along and says...not yet. My read is, it's all good if we have multiple bodies (playing from the same deck) doing trials. There are certain to be differences but so what.

Amit, I am addicted to a belief that the science is valid (3+ yrs study) and (not bullet proof) but far more believable than anything else on the table. When a trial is started by a new body does it not count? Are the amyloid Thesis gene pool still in control? Do the 100's of herbal AD solutions dilute all other news? WhaT?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News